000 01751 a2200481 4500
005 20250513114137.0
264 0 _c19970501
008 199705s 0 0 eng d
022 _a0270-9139
024 7 _a10.1002/hep.510250408
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMcCormick, P A
245 0 0 _aA prospective randomized trial of ceftazidime versus netilmicin plus mezlocillin in the empirical therapy of presumed sepsis in cirrhotic patients.
_h[electronic resource]
260 _bHepatology (Baltimore, Md.)
_cApr 1997
300 _a833-6 p.
_bdigital
500 _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aCeftazidime
_xtherapeutic use
650 0 4 _aCephalosporins
_xtherapeutic use
650 0 4 _aDrug Therapy, Combination
_xadministration & dosage
650 0 4 _aFemale
650 0 4 _aGentamicins
_xadministration & dosage
650 0 4 _aHumans
650 0 4 _aKidney
_xdrug effects
650 0 4 _aLiver Cirrhosis
_xcomplications
650 0 4 _aMale
650 0 4 _aMezlocillin
_xadministration & dosage
650 0 4 _aMiddle Aged
650 0 4 _aNetilmicin
_xadministration & dosage
650 0 4 _aPenicillins
_xadministration & dosage
650 0 4 _aProspective Studies
650 0 4 _aSepsis
_xcomplications
700 1 _aGreenslade, L
700 1 _aKibbler, C C
700 1 _aChin, J K
700 1 _aBurroughs, A K
700 1 _aMcIntyre, N
773 0 _tHepatology (Baltimore, Md.)
_gvol. 25
_gno. 4
_gp. 833-6
856 4 0 _uhttps://doi.org/10.1002/hep.510250408
_zAvailable from publisher's website
999 _c9079383
_d9079383